Accuity
Physician-led pre-bill chart review that recovers earned revenue
Our take
Accuity provides a second-level clinical documentation and coding review that runs post-discharge and pre-bill, after a hospital's own CDI and coding work is complete. Its Amplifi AI engine, trained on more than 7 million chart outcomes, flags charts with likely documentation or coding gaps; 185 multi-specialty physicians plus coders and CDI specialists then review and correct them before the bill drops. Buyers are CFOs, revenue cycle leaders, and CDI/HIM leaders at hospitals who want revenue their teams miss captured compliantly, with a reported 1.5% final denial rate on reviewed cases.
Founded in 2016 by hospital-based physicians and headquartered in Mount Laurel, NJ, Accuity works with more than 50 clients across 400+ hospital sites, including 4 of the top 10 US health systems and Temple Health. It reports $4-6M of net cash recovered per 10,000 inpatient discharges, over $600M in annualized client benefit, and $3.3B in cumulative revenue lift. The engagement model is performance based, opening with a 60-day pilot at no upfront fee. It earned HITRUST r2 certification in 2025. The trade-off versus software: stronger results guarantees, but an ongoing service dependency.
What it does
- Post-discharge, pre-bill second-level chart review
- Amplifi AI trained on 7M+ chart outcomes
- 185 multi-specialty physicians review flagged cases
- DRG, CC/MCC, and quality metric capture
- Medicaid expertise across 38 states
- Compliance oversight with 1.5% final denial rate
Where it's strong
- Runs after your CDI and coding teams finish, so it adds a safety net without changing their workflow.
- Scale is proven: 400+ hospital sites, 4 of the top 10 US health systems, and $3.3B in client revenue lift.
- Performance-based pricing with a 60-day pilot and no upfront fees keeps buyer risk low.
What buyers should weigh
- It is a service engagement, not software your team operates, so capability does not transfer in-house.
- Fees come out of recovered revenue, which costs more at scale than licensing a tool.
- Focused on inpatient pre-bill review; it does not address front-end or denial workflows.
Latest
Reported more than $600M in annualized net cash benefit across 50+ clients and earned HITRUST r2 certification in 2025.
Also in Revenue Integrity & Pre-Bill Review
SmarterDx
Pre-bill AI review that finds missed revenue and quality
Regard
AI that surfaces undocumented diagnoses in the workflow
Iodine Software
Clinical AI for documentation integrity and utilization review
Evidently
EHR-embedded AI that turns scattered chart data into answers
Track this market
First Pass covers Revenue Integrity & Pre-Bill Review and the rest of the getting-paid stack every week.